Skip to Main Content
Wexler Boley & Elgersma LLP
  • Our Firm
    • Who We Serve
      • Shareholders
      • Whistleblowers
      • Consumers
      • Businesses
      • Government Entities
    • Our Professionals
    • Working with Wexler Boley & Elgersma LLP
    • Locations
    • News
    • Careers
    • Report Your Concern
    • Testimonials
  • Practice Areas
    • Antitrust Litigation
    • Business & Commercial Litigation
    • Securities & Corporate Governance
    • Healthcare Litigation
    • Consumer Protection
    • Whistle Blower False Claims Litigation
    • Government Representation
    • Employment Litigation
  • Cases
    • Antitrust Litigation Cases
    • Business & Commercial Litigation Cases
    • Consumer Protection Cases
    • Employment Litigation Cases
    • Government Representation Cases
    • Healthcare Litigation Cases
    • Mass Tort Litigation Cases
    • Securities & Corporate Governance Cases
    • Whistle Blower False Claims Cases
  • Investigations
    • Similac Toxic Infant Formula Lawsuit
    • Kid’s Castle Biometric Privacy Lawsuit
    • Contaminated Baby Food Lawsuit
    • Fatal Sportmix Pet Food Recall Class Action Lawsuit
    • Claire’s Data Breach Lawsuit
    • Insurance Denial for Mental Health and Substance Abuse Treatment
    • Perpetual Sales Litigation
    • Railroad Price-Fixing Lawsuit
    • Medicare Advantage Fraud Litigation
    • Biometric Fingerprinting Litigation
  • Blog
  • Contact Us
See all blog posts
9.1.2011

Women Taking Recalled Supplement

By Makenzie Davis, Editor
In The News, You Should Know, For Consumers

Women are still using a recalled over-the-counter weight-loss supplement.  Pai You Guo was banned by the FDA in 2009, because it contained two drugs: sibutramine, the active ingredient in the now-defunct Abbot drug Meridia, and Phenolpthalein, an ingredient removed from over-the-counter laxatives after it was pegged as a potential carcinogen.

According to a study, one area of the country failed to remove the banned supplement from its shelves, which subsequently gave the illusion that it was okay to buy and use.  A survey of 565 woman found that 23% reported using Pai You Guo, with 85% reporting at least one side effect, including dry mouth, anxiety and insomnia.  The worst part is that 61% of respondents bought the supplement after the product.

It can be very tough to get information out to every segment of the population, said FDA spokeswoman Siobhan DeLancy.  The agency claims to have worked hard with media and consumer groups to get the word out on recalled supplements, but “we are relying on people to come to our site or to read news stories.”

Delancey’s advice to consumers: if you see a supplement with no distributor or manufacturer information on the label, and with packaging in a foreign language, be wary.  And also, be cautious about any supplement that promises very fast weight loss, she said.

If it looks or sounds too good to be true, then it usually is.

Source: Women Still Using Pai You Guo Supplement Despite Ban

Photo Credit: Ragesoss

Share

No Comments

Leave a Reply Cancel reply

Receive News Updates

Get the latest from Wexler Wallace LLP & stay informed.

Categories

  • Media Appearances
  • Uncategorized
  • Columns
    • Guest Post
    • Ken Wexler
    • Ed Wallace
  • Practice Areas
    • Consumer Protection
    • Mass Tort Litigation
    • Business & Commercial Litigation
    • Healthcare Litigation
    • Employment Litigation
  • Cases
  • Hall Of Shame
    • Villain Of The Week
  • In The News
    • Public Victories
  • Featured Investigations
  • The Firm
    • News releases
    • Around The World
    • Our Professionals
    • Chicago
  • You Should Know
    • For Investors
    • For Businesses
    • For Consumers
  • Featured Cases
  • awards
  • Facebook
  • Twitter
  • LinkedIn
Image

311 S. Wacker Drive,
Suite 5450
Chicago, IL 60606
P_312.346.2222
F_312.346.0022

  • Our Firm
  • Practice Areas
  • Cases
  • Investigations
  • Newsroom
  • Blog
  • Contact Us
  • Sitemap
  • Privacy Statement
  • Legal Disclaimer

2022 © Wexler Boley & Elgersma LLP